Clinical and Demographic Characteristics of Patients with COVID-19 Who Died in Modarres Hospital


  • Sara Besharat Clinical Research and Development Center, Department of Radiology, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Nasser Malekpour Alamda Department of Surgery, Critical Care Quality Improvement Research Center at Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Nahid Dadashzadeh Department of Forensic Medicine, Legal Medicine Research Center, Iranian Legal Medicine Organization, Tehran, Iran
  • Ramin Talaie Department of Gastroenterology and Hepatology, School of Medicine, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Seyed Shahram Mousavi Department of Forensic Medicine, Legal Medicine Research Center, Iranian Legal Medicine Organization, Tehran, Iran
  • Abdolrazagh Barzegar Department of Forensic Medicine, Legal Medicine Research Center, Iranian Legal Medicine Organization, Tehran, Iran
  • Sasan Tavana Department of Pulmonary Disease, School of Medicine, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Rohollah Valizadeh Department of Epidemiology, Student Research Committee, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
  • Mehdi Frouzesh Department of Forensic Medicine



COVID-19, Clinical display, Symptoms, Novel coronavirus


BACKGROUND: Novel coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome-CoV2 as a century concern affecting public health.

AIM: This study aimed to find the clinical and demographic characteristics of the patients died following COVID-19 development at Modarres Hospital, Tehran, Iran.

METHODS: In this descriptive-analytical cross-sectional study, 62 patients died following COVID-19 were studied in terms of age, gender, body mass index, comorbidity, symptoms, liver profile, lipid profile, hemoglobin, platelet, white blood cell, lymphocytes, neutrophils, C-reaction protein, polymerase chain reaction (PCR), creatine phosphokinase, creatinine, blood urea nitrogen (BUN), potassium, magnesium, and sodium.

RESULTS: The results showed that 71% of patients were male and 69.4% had positive PCR test indicating low sensitivity of the test; 90.3% of patients were above 60 years old; 56.5 of patients had lymphocytopenia; the mean age was 67.62 ± 15.07 years; with symptoms lasting 6.24 days. The mean serum creatinine and BUN were 3.18 g/dl and 125.9 mg/dl, respectively, indicating renal involvement. All patients had pulmonary involvement accompanied by other organ involvements. Regarding symptoms, 72% of patients showed fever. Some affected patients had diarrhea, lethargy, and fatigue. A comparison of comorbidities by gender showed no significant differences.

CONCLUSION: According to our results, the majority of patients were overweight. In people who are more than 60 years, multi-organ failure was notable. Fever, cough, and shortness of breath were dominant symptoms like other studies, but neurological complications following COVID-19 as meningoencephalitis is possible that can be used as a differential diagnosis. We did not found differences between male and female regarding comorbidity, symptoms, and mortality rate.


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MU, Khan K. Pneumonia of unknown aetiology in Wuhan, China: Potential for international spread via commercial air travel. J Travel Med. 2020;27(2):taaa008. taaa008 PMid:31943059

Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92(4):401-2. PMid:31950516

Mackenzie JS, Smith DW. COVID-19: A novel zoonotic disease caused by a coronavirus from China: What we know and what we don’t. Microbiol Aust. 2020;41:MA20013. https://doi. org/10.1071/ma20013 PMid:32226946

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-9. PMid:32015508

Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214-7. PMid:32007643

Iranian Ministry of Health and Medical Education (MOHME); 2020. Available from: site1/files/Factsheet_4._26.12_-_En.pdf. [Last accessed on 2020 Apr 15].

World Health Organization. Coronavirus Disease 2019 (COVID- 19) Situation Report-101. Geneva: World Health Organization; 2020. Available from: coronaviruse/situation-reports/20200430-sitrep-101-covid-19. pdf?sfvrsn=2ba4e093_2. [Last accessed on 2020 Apr 30].

Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020;92(4):441-7. PMid:31994742

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-207. PMid:31995857

Valizadeh R, Baradaran A, Mirzazadeh A, Bhaskar LV. Coronavirus-nephropathy; renal involvement in COVID-19. J Renal Inj Prev. 2020;9(2):e18. jrip.2020.18

Dadashzadeh N, Farshid S, Valizadeh R, Nanbakhsh M, Rahimi MM. Acute respiratory distress syndrome in COVID-19 disease. Immunopathol Persa. 2020;6(2):e16. https://doi. org/10.34172/ipp.2020.16

Valizadeh R, Dadashzadeh N, Zakeri R, James Kellner S, Rahimi MM. Drug therapy in hospitalized patients with very severe symptoms following COVID-19. J Nephropharmacol. 2020;9(2):e21.

Mubarak M, Nasri N. COVID-19 nephropathy; an emerging condition caused by novel coronavirus infection. J Nephropathol. 2020;9(3):e21.

Lotfi B, Farshid S, Dadashzadeh N, Valizadeh R, Rahimi MM. Is coronavirus disease 2019 (COVID-19) associated with renal involvement? A review of century infection. Jundishapur J Microbiol. 2020;13(4):e102899.

Fortarezza F, Pezzuto F. COVID-19 nephropathy: What could pathologist say? J Nephropathol. 2020;9(4):e32. https://doi. org/10.34172/jnp.2020.32

Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus disease 2019 (COVID-19) and pregnancy: What obstetricians need to know. Am J Obstet Gynecol. 2020;222:415-26. PMid:32105680

Dolatian M, Mahmoodi Z, Alavi-Majd H, Moafi F, Ghorbani M, Mirabzadeh A. Psychosocial factors in pregnancy and birthweight: Path analysis. J Obstet Gynaecol Res. 2016;42(7):822-30. PMid:27098096

Mahmoodi Z, Karimlou M, Sajjadi H, Dejman M, Vameghi M. Development of mother’s lifestyle scale during pregnancy with an approach to social determinants of health. Glob J Health Sci. 2013;5(3):208-19. PMid:23618491

Dolatian M, Mirabzadeh A, Forouzan AS, Sajjadi H, Alavimajd H, Mahmoodi Z, et al. Relationship between structural and intermediary determinants of health and preterm delivery. J Reprod Infertil. 2014;15(2):78-86. PMid:24918080

Ghelichi-Ghojogh M, Allah Kalteh E, Fararooei M. Coronavirus disease 2019; epidemiology and recommendations. J Prev Epidemiol. 2020;5(1):e01.

Forouzesh M, Rahimi A, Valizadeh R, Dadashzadeh N, Mirzazadeh A. Clinical display, diagnostics and genetic implication of novel coronavirus (COVID-19) epidemic. Eur Rev Med Pharmacol Sci. 2020;24(8):4607-15. PMid:32374001

Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID- 19) in China: A systematic review and meta-analysis. J Infect. 2020;80(6):656-65. PMid:32283155

Colaneri M, Sacchi P, Zuccaro V, Biscarini S, Sachs M, Roda S, et al. Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020. Euro Surveill. 2020;25(16):2000460. https:// PMid:32347201

Baymakova M, Popov GT. COVID-19: A review of part of the international experience. Med Rev (Sofia). 2020;56(3):5-13.

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574-81. https:// PMid:32250385

Daneshfar M, Dadashzadeh N, Ahmadpour M, Ragati Haghi H, Rahmani V, Forouzesh M, et al. Lessons of mortality following COVID-19 epidemic in the United States especially in the geriatrics. J Nephropharmacol. 2021;10(1):e06. https://doi. org/10.34172/npj.2021.06

Jahromi AH, Mahmoudi H. Real estimates of mortality following COVID-19 infection; an oversimplification of a complex issue. J Prev Epidemiol. 2020;5(1):e04. jpe.2020.04

Jiang G, Ren X, Liu Y, Chen H, Liu W, Guo Z, et al. Application and Optimization of RT-PCR in Diagnosis of SARS-CoV-2 Infection. New York: medRxiv; 2020. Available from: https:// [Last accessed on 2020 Mar 22].

Ritter S. The absolute lymphocyte count (ALC) is a significant clue for immune deficiency. J Allergy Clin Immunol. 2019;143(2):AB115.

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ. 2020;368:m792. https://doi. org/10.1136/bmj.m792 PMid:32075786

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with Covid-19 in the New York City Area. JAMA. 2020;323(20):2052-9. https:// PMid:32320003

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi. org/10.1016/s0140-6736(20)30183-5




How to Cite

Besharat S, Alamda NM, Dadashzadeh N, Talaie R, Mousavi SS, Barzegar A, Tavana S, Valizadeh R, Frouzesh M. Clinical and Demographic Characteristics of Patients with COVID-19 Who Died in Modarres Hospital. Open Access Maced J Med Sci [Internet]. 2020 Sep. 20 [cited 2021 Dec. 4];8(T1):144-9. Available from: